Novavax shareholder Shah Capital to step back from activist role
Shah Capital, one of Novavax’s top shareholders, said on Friday it no longer seeks to influence control of the vaccine maker after restructuring into a family office.
Shah Capital, one of Novavax’s top shareholders, said on Friday it no longer seeks to influence control of the vaccine maker after restructuring into a family office.